Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02389309
Brief Title: Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

First Submitted : March 4, 2015
First Submitted that Met QC Criteria : March 16, 2015
First Posted : March 17, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 8, 2020
Last Update Posted : January 10, 2020